A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The study will assess the long-term safety and tolerability of AIN457 in patients with
relapsing-remitting multiple sclerosis (RRMS). In addition the long-term pattern of
maintenance of efficacy and health related quality of life will be explored.